Hybrid coronary revascularization: Time for a new comparator?

Key Points The present meta‐analysis found no significant difference between hybrid coronary revascularization (HCR) and bypass surgery (CABG) regarding intermediate‐term major adverse cardiac and cerebrovascular events. HCR is feasible, historically with higher revascularization rates but less perioperative morbidity With a comparable frequency of repeat revascularization between current‐generation drug‐eluting stents and CABG, future trials of HCR are considering multi‐vessel PCI as the new comparator.

http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fccd.27503

Source: Catheterization and Cardiovascular Interventions - February 6, 2018 Category: Cardiovascular & Thoracic Surgery Authors: Naoki Misumida, David J. Moliterno Tags: Coronary Artery Disease Source Type: research